The concept of nearshore manufacturing in biopharmaceuticals in Serbia reflects a growing trend in the global pharmaceutical industry, emphasizing strategic geographic placement to optimize production efficiency, cost, and market accessibility. Serbia, with its advantageous position and evolving economic landscape, presents an intriguing opportunity for biopharmaceutical companies, particularly those based in the European Union (EU). This...